Can simvastatin promote tumor growth by inducing angiogenesis similar to VEGF?
- 31 January 2002
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 58 (1) , 85-86
- https://doi.org/10.1054/mehy.2001.1465
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Ischemia-Induced Coronary Collateral Growth Is Dependent on Vascular Endothelial Growth Factor and Nitric OxideCirculation, 2000
- Simvastatin upregulates coronary vascular endothelial nitric oxide production in conscious dogsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2000
- Angiogenesis in cancer and other diseasesNature, 2000
- The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.Nature Medicine, 2000
- Follow-up study of patients randomized in the scandinavian simvastatin survival study (4S) of cholesterol loweringThe American Journal of Cardiology, 2000
- Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemiaJournal of the American College of Cardiology, 2000
- Nitric Oxide Synthase Inhibition by NG-Nitro-l-Arginine Methyl Ester Inhibits Tumor-Induced Angiogenesis in Mammary TumorsThe American Journal of Pathology, 1999
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESISThe Journal of Experimental Medicine, 1971